Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W T Beck

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1988
Comparison of ion channels in multidrug-resistant and -sensitive human leukemic cellsS C Lee, C Deutsch, W T Beck
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1999
Functional interaction between human topoisomerase IIalpha and retinoblastoma proteinU G Bhat, P Raychaudhuri, W T Beck
Cancer Research|November 26, 1997
Down-regulation of topoisomerase IIalpha in CEM cells selected for merbarone resistance is associated with reduced expression of Sp3Y Y Mo, Q Wang, W T Beck
Molecular Pharmacology|April 1, 1988
Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cellsJ M Zamora, H L Pearce, W T Beck
Nature|January 26, 1973
Puromycin stimulation of rat liver ornithine decarboxylase activityW T Beck, R A Bellantone, E S Canellakis
Molecular Pharmacology|November 1, 1983
Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblastsW T Beck, M C Cirtain, J L Lefko
Molecular Pharmacology|February 1, 1996
Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cellsE G Schuetz, W T Beck, J D Schuetz
Biochemical Society Transactions|November 16, 2001
Cytotoxic signalling by inhibitors of DNA topoisomerase IIW T Beck, Y Y Mo, U G Bhat
Cancer Research|March 1, 1987
Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26)M K Danks, J C Yalowich, W T Beck
Biochemical Pharmacology|April 15, 1982
Biochemical basis for impaired drug metabolism in tumor-bearing rats. Evidence for altered regulation of hepatic microsomal hemeprotein synthesisW T Beck, M L Dedmon, M A Ouellette
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1988
Comparison of ion channels in multidrug-resistant and -sensitive human leukemic cellsS C Lee, C Deutsch, W T Beck
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1999
Functional interaction between human topoisomerase IIalpha and retinoblastoma proteinU G Bhat, P Raychaudhuri, W T Beck
Cancer Research|November 26, 1997
Down-regulation of topoisomerase IIalpha in CEM cells selected for merbarone resistance is associated with reduced expression of Sp3Y Y Mo, Q Wang, W T Beck
Molecular Pharmacology|April 1, 1988
Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cellsJ M Zamora, H L Pearce, W T Beck
Nature|January 26, 1973
Puromycin stimulation of rat liver ornithine decarboxylase activityW T Beck, R A Bellantone, E S Canellakis
Molecular Pharmacology|November 1, 1983
Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblastsW T Beck, M C Cirtain, J L Lefko
Molecular Pharmacology|February 1, 1996
Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cellsE G Schuetz, W T Beck, J D Schuetz
Biochemical Society Transactions|November 16, 2001
Cytotoxic signalling by inhibitors of DNA topoisomerase IIW T Beck, Y Y Mo, U G Bhat
Cancer Research|March 1, 1987
Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26)M K Danks, J C Yalowich, W T Beck
Biochemical Pharmacology|April 15, 1982
Biochemical basis for impaired drug metabolism in tumor-bearing rats. Evidence for altered regulation of hepatic microsomal hemeprotein synthesisW T Beck, M L Dedmon, M A Ouellette
Pageof 11